EA2496 Laboratoire Pathologies et Biothérapies de l'Organe Dentaire, Faculté de Chirurgie Dentaire, Université Paris Descartes, Sorbonne Paris Cité, 1 rue Maurice Arnoux 92120 Montrouge, France.
Bone. 2012 May;50(5):1162-72. doi: 10.1016/j.bone.2012.01.023. Epub 2012 Feb 2.
Bone remodeling, the mechanism that modulates bone mass adaptation, is controlled by the sympathetic nervous system through the catecholaminergic pathway. However, resorption in the mandible periosteum envelope is associated with cholinergic Vasoactive Intestinal Peptide (VIP)-positive nerve fibers sensitive to sympathetic neurotoxics, suggesting that different sympathetic pathways may control distinct bone envelopes. In this study, we assessed the role of distinct sympathetic pathways on rat femur and mandible envelopes. To this goal, adult male Wistar rats were chemically sympathectomized or treated with agonists/antagonists of the catecholaminergic and cholinergic pathways; femora and mandibles were sampled. Histomorphometric analysis showed that sympathectomy decreased the number of preosteoclasts and RANKL-expressing osteoblasts in mandible periosteum but had no effect on femur trabecular bone. In contrast, pharmacological stimulation or repression of the catecholaminergic cell receptors impacted the femur trabecular bone and mandible endosteal retromolar zone. VIP treatment of sympathectomized rats rescued the disturbances of the mandible periosteum and alveolar wall whereas the cholinergic pathway had no effect on the catecholaminergic-dependent envelopes. We also found that VIP receptor-1 was weakly expressed in periosteal osteoblasts in the mandible and was increased by VIP treatment, whereas osteoblasts of the retromolar envelope that was innervated only by tyrosine hydroxylase-immunoreactive fibers, constitutively expressed beta-2 adrenergic receptors. These data highlight the complexity of the sympathetic control of bone metabolism. Both the embryological origin of the bone (endochondral for the femur, membranous for the mandibular periosteum and the socket wall) and environmental factors specific to the innervated envelope may influence the phenotype of the sympathetic innervation. We suggest that an origin-dependent imprint of bone cells through osteoblast-nerve interactions determines the type of autonomous system innervating a particular bone envelope.
骨重塑是调节骨量适应性的机制,它受到交感神经系统通过儿茶酚胺能途径的控制。然而,下颌骨骨膜包膜的吸收与胆碱能血管活性肠肽(VIP)阳性神经纤维有关,这些神经纤维对交感神经毒素敏感,这表明不同的交感途径可能控制不同的骨包膜。在这项研究中,我们评估了不同交感途径对大鼠股骨和下颌骨包膜的作用。为此,成年雄性 Wistar 大鼠进行化学性交感神经切除术或给予儿茶酚胺能和胆碱能途径的激动剂/拮抗剂治疗;采集股骨和下颌骨样本。组织形态计量学分析显示,交感神经切除术减少了下颌骨骨膜中的破骨前体细胞和 RANKL 表达的成骨细胞数量,但对股骨小梁骨没有影响。相比之下,儿茶酚胺能细胞受体的药理学刺激或抑制作用影响了股骨小梁骨和下颌骨内骨后磨牙区。给予 VIP 治疗可挽救交感神经切除大鼠下颌骨骨膜和牙槽骨壁的紊乱,而胆碱能途径对依赖儿茶酚胺的包膜没有影响。我们还发现,VIP 受体-1 在下颌骨骨膜中的成骨细胞中弱表达,并被 VIP 治疗所增加,而仅由酪氨酸羟化酶免疫反应性纤维支配的磨牙后包膜中的成骨细胞则持续表达β-2 肾上腺素能受体。这些数据突出了交感神经对骨代谢的控制的复杂性。骨的胚胎起源(股骨为软骨内,下颌骨骨膜和牙槽骨壁为膜内)和支配包膜的特定环境因素都可能影响交感神经支配的表型。我们认为,骨细胞通过成骨细胞-神经相互作用的起源依赖性印记决定了支配特定骨包膜的自主系统的类型。